Tearsheet
Investment Highlights Market Valuation Price Chart Business Description Interactive Breakdown Latest Trefis Analyses Better Bets vs. VEEV Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Veeva Systems (VEEV)

Market Price (9/16/2025): $276.13 | Market Cap: $45.1 Bil
Sector: Health Care | Industry: Health Care Technology

Veeva Systems (VEEV)

Market Price (9/16/2025): $276.13
Market Cap: $45.1 Bil
Sector: Health Care
Industry: Health Care Technology

Investment Highlights

0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -14%		 Weak multi-year price returns
2Y Excs Rtn is -25%, 3Y Excs Rtn is -6.9%		 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 57x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 33x, P/EPrice/Earnings or Price/(Net Income) is 56x
1 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 27%		  Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.7%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 45%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 45%		  
3 Low stock price volatility
Vol 12M is 35%		  
0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -14%
1 Attractive operating margins
Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 27%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 45%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 45%
3 Low stock price volatility
Vol 12M is 35%
4 Weak multi-year price returns
2Y Excs Rtn is -25%, 3Y Excs Rtn is -6.9%
5 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 57x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 33x, P/EPrice/Earnings or Price/(Net Income) is 56x
6 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.7%

Market Valuation

 9/16/25202420232022
Share Price CYE$276.13$210.25$192.52$161.38
Market Cap CYE ($ Bil)45.134.131.025.1
Total Debt ($ Bil)0.10.10.10.1
Total Cash ($ Bil)6.45.24.03.1
Enterprise Value ($ Bil)38.834.231.125.2
Valuation Ratios    
P/S TTM15.212.413.111.6
P/EBIT TTM56.549.272.054.6
P/E TTM55.747.758.851.4
Sector Ratios    
P/S TTM (Sector)3.83.64.14.5
P/EBIT TTM (Sector)-1.6-1.3-1.4-1.3
P/E TTM (Sector)-1.9-1.6-1.5-1.4
 9/16/252024
Share Price CYE$276.13$210.25
Market Cap CYE ($ Bil)45.134.1
Total Debt ($ Bil)0.10.1
Total Cash ($ Bil)6.45.2
Enterprise Value ($ Bil)38.834.2
Valuation Ratios  
P/S TTM15.212.4
P/EBIT TTM56.549.2
P/E TTM55.747.7
Sector Ratios  
P/S TTM (Sector)3.83.6
P/EBIT TTM (Sector)-1.6-1.3
P/E TTM (Sector)-1.9-1.6

Market Cap Chart

Business Description

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. Show more

Price Returns Compared

Expand for Detailed View

 202020212022202320242025Total [1]
Returns
VEEV Return94%-6%-37%19%9%31%97%
Peers Return56%-13%-53%12%3%4%-23%
S&P 500 Return16%27%-19%24%23%12%104%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: OMCL, SDGR, TDOC, VEEV, DOCS. See VEEV Returns vs. Peers.
[3] 2025 data is for the year up to 9/15/2025 (YTD)

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Veeva Systems Earnings Notes  
2VEEV At Price Support Zone, Right Time To Buy?Actionable 
3Wait For A Dip To Buy Veeva Systems StockBuy or Fear 
4As VEEV Falls 7.2% in a Day, DOCS's Story Stands OutCounter-Intuitive Comparisons 
5How Does VEEV Stack Up Against Its Peers?Peer Comparison 
6Better Bet Than VEEV Stock: Pay Less Than Veeva Systems To Get More From NVDA, LLY   
7Better Bet Than VEEV Stock: Pay Less Than Veeva Systems To Get More From LLY, BMRN   
8VEEV Dip Buy Analysis  
9Wait For A Dip To Buy Veeva Systems StockBuy or Fear 
10Veeva Systems Total Shareholder Return (TSR): 12.5% in 2025 and -0.5% 3-yr compounded annual returns (above peer average)  
11ARTICLES  
12VEEV Hits Key Support – Is This The Buying Opportunity? August 30th, 2025
13VEEV Dips 7.2% In One Day, Wait For A Dip To Buy The Stock August 29th, 2025
14VEEV’s 7.2% One Day Dip Begs The Question: Is DOCS Better Instead? August 29th, 2025
15VEEV Dropped 7.2% In A Day. Have You Fully Evaluated The Risk? August 29th, 2025
16Large Cap Stocks Trading At 52-Week High August 27th, 2025
Title
0DASHBOARDS
1VEEV Hits Key Support – Is This The Buying Opportunity?
2VEEV Dips 7.2% In One Day, Wait For A Dip To Buy The Stock
3VEEV’s 7.2% One Day Dip Begs The Question: Is DOCS Better Instead?
4VEEV Dropped 7.2% In A Day. Have You Fully Evaluated The Risk?
5Large Cap Stocks Trading At 52-Week High
6ARTICLES
7Veeva Systems Earnings Notes
8VEEV At Price Support Zone, Right Time To Buy?
9Wait For A Dip To Buy Veeva Systems Stock
10As VEEV Falls 7.2% in a Day, DOCS's Story Stands Out
11How Does VEEV Stack Up Against Its Peers?
12Better Bet Than VEEV Stock: Pay Less Than Veeva Systems To Get More From NVDA, LLY 
13Better Bet Than VEEV Stock: Pay Less Than Veeva Systems To Get More From LLY, BMRN 
14VEEV Dip Buy Analysis
15Wait For A Dip To Buy Veeva Systems Stock
16Veeva Systems Total Shareholder Return (TSR): 12.5% in 2025 and -0.5% 3-yr compounded annual returns (above peer average)

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1NXTTNext Technology18985.5%1080.3%
2BDSXBiodesix1658.4%-75.2%
3VCIGVCI Global1460.0%-66.8%
4CLSDClearside Biomedical1075.2%-72.3%
5SDOTSadot806.7%-78.2%
6WLDSWearable Devices539.8%-24.4%
7QMMMQMMM536.6%5505.5%
8ATCHAtlasClear382.9%-89.7%
9OPIOffice Properties Income Trust274.5%-8.3%
10CWDCaliberCos246.5%-46.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1DGNXDiginex-83.7% 
2ATYRaTyr Pharma-81.4%-72.0%
3LGCLLucas GC-73.2%-78.3%
4NAKAKindly MD-72.8% 
5OCTOEightco-67.8%562.1%
6YYGHYY-67.0%-78.2%
7SNTGSentage-58.1%57.5%
8REXREX American Resources-50.7%-26.7%
9BINIBollinger Innovations-49.2%-100.0%
10SLXNSilexion Therapeutics-49.2%-88.0%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical11963.5%11963.5%
2GIBOGIBO7309.3% 
3CHSNChanson International5551.3%-99.3%
4LNZALanzaTech Global5145.9%-85.7%
5QMMMQMMM2490.3%5505.5%
6NXTTNext Technology2167.7%1080.3%
7VTAKCatheter Precision1543.9%-70.5%
8CURXCuranex Pharmaceuticals1282.0%1282.0%
9VCIGVCI Global1278.3%-66.8%
10OCTOEightco800.6%562.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1CJETChijet Motor-93.3%-95.1%
2ELPWElong Power-92.4%-76.5%
3STFSStar Fashion Culture-92.1%-97.9%
4ETSElite Express-92.0%-92.0%
5NAKAKindly MD-91.7% 
6BINIBollinger Innovations-90.5%-100.0%
7FLYEFly-E-89.8%-81.2%
8JEM707 Cayman-89.8%-98.3%
9NUTRNusaTrip-86.7%-86.7%
10CUPRCuprina-84.9% 

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1NXTTNext Technology18985.5%1080.3%
2BDSXBiodesix1658.4%-75.2%
3VCIGVCI Global1460.0%-66.8%
4CLSDClearside Biomedical1075.2%-72.3%
5SDOTSadot806.7%-78.2%
6WLDSWearable Devices539.8%-24.4%
7QMMMQMMM536.6%5505.5%
8ATCHAtlasClear382.9%-89.7%
9OPIOffice Properties Income Trust274.5%-8.3%
10CWDCaliberCos246.5%-46.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1DGNXDiginex-83.7% 
2ATYRaTyr Pharma-81.4%-72.0%
3LGCLLucas GC-73.2%-78.3%
4NAKAKindly MD-72.8% 
5OCTOEightco-67.8%562.1%
6YYGHYY-67.0%-78.2%
7SNTGSentage-58.1%57.5%
8REXREX American Resources-50.7%-26.7%
9BINIBollinger Innovations-49.2%-100.0%
10SLXNSilexion Therapeutics-49.2%-88.0%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Veeva Systems

Financials

VEEVOMCLSDGRTDOCDOCSMedian
NameVeeva Sy.Omnicell Schrodin.Teladoc .Doximity  
Mkt Price276.2732.2618.467.6772.4732.26
Mkt Cap45.21.51.41.313.61.5
Rev LTM2,9681,1502382,5425901,150
Op Inc LTM79915-193-18323915
FCF LTM1,3498924151287151
FCF 3Y Avg1,108123-95137212137
CFO LTM1,34914827303294294
CFO 3Y Avg1,108180-86293218218

Growth & Margins

VEEVOMCLSDGRTDOCDOCSMedian
NameVeeva Sy.Omnicell Schrodin.Teladoc .Doximity  
Rev Chg LTM15.3%6.4%18.6%-2.6%19.4%15.3%
Rev Chg 3Y Avg14.1%-2.6%13.6%4.6%17.8%13.6%
Rev Chg Q16.7%5.0%15.7%-1.6%15.2%15.2%
QoQ Delta Rev Chg LTM4.0%1.2%3.2%-0.4%3.4%3.2%
Op Mgn LTM26.9%1.3%-81.1%-7.2%40.5%1.3%
Op Mgn 3Y Avg22.5%-1.7%-89.9%-8.1%36.4%-1.7%
QoQ Delta Op Mgn LTM-0.0%0.4%2.5%0.1%0.1%0.1%
CFO/Rev LTM45.5%12.9%11.6%11.9%49.9%12.9%
CFO/Rev 3Y Avg42.7%15.7%-44.1%11.4%42.6%15.7%
FCF/Rev LTM45.5%7.8%10.2%5.9%48.7%10.2%
FCF/Rev 3Y Avg42.7%10.7%-48.4%5.3%41.4%10.7%

Valuation

VEEVOMCLSDGRTDOCDOCSMedian
NameVeeva Sy.Omnicell Schrodin.Teladoc .Doximity  
Mkt Cap45.21.51.41.313.61.5
P/S15.21.35.70.523.15.7
P/EBIT56.597.6-7.0-6.457.156.5
P/E55.865.4-7.5-6.557.955.8
P/CFO33.510.249.34.446.333.5
Total Yield1.8%1.5%-13.4%-15.4%1.7%1.5%
Dividend Yield0.0%0.0%0.0%0.0%0.0%0.0%
FCF Yield 3Y Avg3.1%7.5%-5.1%7.7%2.8%3.1%
D/E0.00.30.10.80.00.1
Net D/E-0.1-0.0-0.20.3-0.1-0.1

Returns

VEEVOMCLSDGRTDOCDOCSMedian
NameVeeva Sy.Omnicell Schrodin.Teladoc .Doximity  
1M Rtn-1.5%1.8%-4.7%2.0%11.3%1.8%
3M Rtn-2.9%10.4%-12.9%9.3%29.5%9.3%
6M Rtn16.6%-2.9%-22.2%-13.5%16.1%-2.9%
12M Rtn26.8%-25.3%-11.0%-5.2%84.3%-5.2%
3Y Rtn57.8%-66.1%-33.4%-74.8%130.4%-33.4%
1M Excs Rtn-1.8%0.2%-7.4%2.8%11.8%0.2%
3M Excs Rtn-12.9%-0.4%-24.5%1.1%18.9%-0.4%
6M Excs Rtn0.7%-19.6%-36.7%-28.3%-3.0%-19.6%
12M Excs Rtn4.3%-44.2%-29.4%-14.0%77.7%-14.0%
3Y Excs Rtn-6.9%-133.4%-100.1%-141.5%48.7%-100.1%

Comparison Analyses

Financials

$ Mil | FY: 1/312026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q3
Period End7/31/20254/30/20251/31/202510/31/20247/31/20244/30/20241/31/202410/31/20237/31/20234/30/20231/31/202310/31/2022
Filing Date8/29/20256/2/20253/24/202512/9/20249/4/20246/4/20243/25/202412/7/20239/1/20236/2/20233/30/202312/7/2022
Key Financials Quarterly            
Total Revenue789759721699676650631617590526563552
Ebitda20624419819117816414413711269117129
Operating Income19623418818116615513512810462109121
Net Income200228196186171162147135112132189108
EPS1.231.401.201.151.061.000.920.840.700.821.200.70
Key Financials TTM            
Total Revenue TTM2,9682,8552,7472,6562,5742,4882,3642,2962,2322,1762,1552,077
Ebitda TTM839811731676622557462435426423488498
Operating Income TTM799770691638585523429403396393459470
Net Income TTM810781714666615556526567540519488396
Growth Rates Quarterly            
Total Revenue Growth16.7%16.7%14.3%13.4%14.6%23.6%11.9%11.6%10.5%4.2%16.0%16.0%
EBITDA Growth16.1%48.8%37.8%39.8%58.3%136.9%23.4%6.4%3.5%-48.7%-8.0%-7.9%
Operating Income Growth17.7%50.6%39.3%41.1%60.0%152.2%24.2%5.8%2.9%-51.8%-9.0%-8.5%
Net Income Growth17.1%41.2%32.7%37.5%53.2%22.9%-21.8%24.6%23.2%31.4%94.2%2.4%
Margins Quarterly            
EBITDA Margin26.1%32.1%27.5%27.4%26.3%25.2%22.8%22.2%19.0%13.1%20.7%23.3%
Operating Income Margin24.8%30.8%26.1%25.9%24.6%23.9%21.4%20.8%17.6%11.7%19.3%22.0%
Net Income Margin25.4%30.1%27.1%26.6%25.3%24.9%23.4%21.9%18.9%25.0%33.5%19.6%
Cash & Debt            
Total Cash6,4046,0685,1505,0634,8854,7654,0283,9423,8693,6153,1033,023
Total Debt857776725456565859586162
Net Debt / (Cash)-6,318-5,991-5,074-4,991-4,831-4,709-3,972-3,885-3,810-3,557-3,042-2,961
Cash Flows Quarterly            
FCF from Operations2388777016493764588326550663143
Cash Flows TTM            
FCF from Operations TTM1,3491,2041,0901,0789971,169911917977805780771
Returns to Shareholders Quarterly            
Dividends000000000000
Share Repurchases-0-0-0-0-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly            
ROIC------------
Return on Invested Capital (ROIC) TTM            
ROIC TTM------------

Segment Financials

Revenue by Segment

$ Mil20252024202320222021
Subscription services1,9021,7331,4841,179896
Professional services462422367286208
Total2,3642,1551,8511,4651,104


Price Behavior

VEEV Betas & Captures as of 8/31/2025

 1M2M3M6M1Y3Y
Beta0.880.860.590.610.650.89
Up Beta2.100.900.780.440.450.75
Down Beta0.591.030.490.560.580.74
Up Capture4%36%25%93%91%98%
Bmk +ve Days10223571142415
Stock +ve Days10182961120367
Down Capture116%135%90%79%90%102%
Bmk -ve Days11192754106334
Stock -ve Days11233364128382

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date8292025
Short Interest: Shares Quantity5,043,197
Short Interest: % Change Since 81520257.5%
Average Daily Volume1,699,118
Days-to-Cover Short Interest2.97
Basic Shares Quantity163,496,000
Short % of Basic Shares3.1%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/27/2025-7.2%-8.0% 
5/28/202519.0%20.9%20.9%
3/5/20257.4%6.1%0.7%
11/8/20245.2%2.8%10.1%
8/28/20248.9%8.0%5.8%
5/30/2024-10.3%-4.7%-6.4%
2/29/2024-1.6%2.1%2.2%
11/9/2023-14.2%-8.9%-11.0%
...
SUMMARY STATS   
# Positive121413
# Negative121011
Median Positive7.9%5.1%8.5%
Median Negative-7.8%-9.2%-10.1%
Max Positive19.7%20.9%21.6%
Max Negative-16.2%-18.2%-17.3%

SEC Filings

Expand for More

Report DateFiling DateFiling
7312025829202510-Q 7/31/2025
4302025602202510-Q 4/30/2025
1312025324202510-K 1/31/2025
103120241209202410-Q 10/31/2024
7312024904202410-Q 7/31/2024
4302024604202410-Q 4/30/2024
1312024325202410-K 1/31/2024
103120231207202310-Q 10/31/2023
7312023901202310-Q 7/31/2023
4302023602202310-Q 4/30/2023
1312023330202310-K 1/31/2023
103120221207202210-Q 10/31/2022
7312022902202210-Q 7/31/2022
4302022603202210-Q 4/30/2022
1312022330202210-K 1/31/2022
103120211203202110-Q 10/31/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0Faddis JonathanSVP, Gen. Counsel, Secretary7112025Sell285.62720205,6462,256,969Form
1Cabral Timothy S 6092025Sell289.7231591,2621,593,460Form
2Schwenger Thomas D.Pres. & Chief Customer Officer6022025Sell268.111,150308,3246,632,709Form
3Faddis JonathanSVP, Gen. Counsel, Secretary5052025Sell236.71833197,1791,854,623Form
4Schwenger Thomas D.Pres. & Chief Customer Officer4152025Sell220.76802177,0515,803,168Form

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.